Bausch Health Companies Inc

Bausch Health Companies Inc

BHC - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$4.29B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bausch Health Companies IncBausch Health Companies Inc-3.6-46%0.3-0.5
$8.50

Target Price by Analysts

6% upsideBausch Health Companies Target Price DetailsTarget Price
$12.18

Current Fair Value

51.8% upside

Undervalued by 51.8% based on the discounted cash flow analysis.

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$4.29 Billion
Enterprise Value$4.26 Billion
Earnings per Share$0.43
Beta0.37
Outstanding Shares375,500,000

Return

Return on Equity45.99%ROE
Return on Assets-3.29%
Return on Invested Capital13.99%

Valuation & Multiples

P/E Ratio-3.61P/E Ratio
PEG-2.48PEG
Price to Sales0.31Price to Sales
Price to Book Ratio-2.67Price to Book Ratio
Enterprise Value to Revenue0.43
Enterprise Value to EBIT1.5
Enterprise Value to Net Income-6
Total Debt to Enterprise0.2
Debt to Equity-0.49Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 28, 2026
EPS Estimate
$1.25
Consensus analyst estimate
Revenue Estimate
$2.72 B
Consensus analyst estimate

Next Earnings Call

Expected Date
November 4, 2026
EPS Estimate
$1.17
Consensus analyst estimate
Revenue Estimate
$2.68 B
Consensus analyst estimate

Institutional Put/Call Ratio

Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.

Put/Call Ratio0.0000▼ 236.27%
Total Calls48,700▼ 98.74%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.53%▼ 63.29%
Total Invested$12.47M▼ 98.95%
Investors Holding48▼ 195.00%

About Bausch Health Companies Inc

21,100 employees
CEO: Thomas J. Appio

Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter ...

Bausch Health Companies Insider Information FAQ

Stockcircle tracks 8 top investors with a current 13F position in Bausch Health Companies. Notable holders include Bridgewater Associates. Holdings come from the latest quarterly 13F filings filed with the SEC.

In the latest 13F quarter on Stockcircle, 3 top investors increased or opened positions and 5 top investors reduced or sold among tracked top investors. Changes are based on reported share counts in their quarterly filings, not day-to-day trading.

Stockcircle shows 2 open-market insider sales for Bausch Health Companies in the last six months from SEC Form 4 reports by executives, directors, and other insiders.

Form 4 insider trades are added as new filings are imported. Top investor 13F holdings refresh after each quarterly filing cycle. Politician trade disclosures are added when new reports are published on Stockcircle.